CN Bio Innovations is at the forefront of developing Organ-on-Chip and microfluidics technologies as superior alternatives to animal testing.
Tools for predictive biology
CN Bio’s systems and life science tools allow scientists to gather accurate predictive data about whether drugs, cosmetics and other chemicals will be safe and effective for humans.
Accelerating healthcare innovation
The pace of new drug development has been declining, in large part because safety and efficacy in humans is not well predicted by animal studies. To realise the benefits of personalized medicine, clinicians also require precise data for patient stratification.
Human relevant data
CN Bio’s microfluidic chips replicate the structure and function of human organs, and enable precise control over tissue microenvironment so that physiological processes and drug exposures can be replicated in vitro.
- Open-well device, rather than a closed lab-on-chip. Intuitive to use, enables easy access to cells and cell culture media for analysis (by humans or automated processes)
- Materials of construction carefully selected and optimised to minimise drug sorption
- The number of cells to the volume of media in each well has been optimised to allow a wide variety of analysis (e.g. –omics)
- Extremely robust pneumatically actuated fluidics
We would be delighted to send you a set of datasheets, case studies, publications or additional information about CN Bio’s instrumentation and systems tailored to your interests and requirements. Please help us do this by filling out the form below.
When we require you to enter personal information, we will only do so to allow us to respond to your request. Your contact details will not be added to a mailing list and we will not disclose them without your consent.